Skip to main content
. 2020 May 18;22:35. doi: 10.1186/s12968-020-00626-y

Table 2.

Baseline patient characteristics

Parameter Value
Age, years 48 ± 12
Gender male/female, n (%) 13 (57%) / 10 (43%)
Height, cm 179 ± 9
Weight, kg 87 ± 18
BMI, kg/m2 27 ± 4
BSA, m2 2.0 ± 0.2
NYHA class I / II / III / IV, n (%) 11 (48%) / 5 (22%) / 3 (13%) / 0 (0%)
Indication for S-ICD implantation, n (%)
Suspected non-ischemic cardiomyopathy with LVEF ≤35% 5 (22%)
Suspected ischemic cardiomyopathy with LVEF ≤35% 1 (4%)
Ventricular arrhythmia of unknown origin 17 (74%)
Primary vs. secondary prophylaxis, n (%) 8 (35%) vs. 15 (65%)

BMI body mass index; S-ICD subcutaneous implanted cardioverter/defibrillator; LVEF left ventricular ejection fraction